Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

BACKGROUND: The optimal dose of radioactive iodine (RAI) therapy for N1b papillary thyroid carcinoma (PTC) is controversial. We evaluated the clinical outcome of N1b PTC patients treated with either 100 or 150 mCi of RAI. METHODS: We retrospectively analyzed N1b PTC patients who underwent total thyr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinol Metab (Seoul)
Autors principals: Jin, Meihua, Ahn, Jonghwa, Lee, Yu-Mi, Sung, Tae-Yon, Kim, Won Gu, Kim, Tae Yong, Ryu, Jin-Sook, Kim, Won Bae, Shong, Young Kee, Jeon, Min Ji
Format: Artigo
Idioma:Inglês
Publicat: Korean Endocrine Society 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520585/
https://ncbi.nlm.nih.gov/pubmed/32981302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.741
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars